Trial · NCT03054350
Results by group194
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 194
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Vadadustat 150 mg | -0.28 | Standard Error 0.218 | grams per deciliter (g/dL) | |
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Vadadustat 300 mg | 0.08 | Standard Error 0.222 | grams per deciliter (g/dL) | |
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Vadadustat 600 mg | 0.41 | Standard Error 0.233 | grams per deciliter (g/dL) | |
| Mean Change in Hemoglobin (Hb) Levels From Pre-treatment to the End of the Primary Efficacy Period | Placebo | -1.48 | Standard Error 0.226 | grams per deciliter (g/dL) | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Vadadustat 150 mg | 69.3 | Standard Deviation 25.31 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Vadadustat 300 mg | 79.2 | Standard Deviation 24.94 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Vadadustat 600 mg | 54.6 | Standard Deviation 27.90 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Placebo to Vadadustat 300 mg | 57.0 | Standard Deviation 19.80 | days | |
| Time to Reach the Target Hb Level of 10.0 to 12.0 g/dL From Baseline up to Week 16 | Placebo to Vadadustat 600 mg | 85.0 | Standard Deviation NA | days | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Vadadustat 150 mg | 9.064 | Standard Deviation 1.0652 | g/dL | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Vadadustat 300 mg | 9.062 | Standard Deviation 0.8412 | g/dL | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Vadadustat 600 mg | 9.969 | Standard Deviation 0.7296 | g/dL | |
| Mean Hb Levels at the End of the Primary Efficacy Period | Placebo | 7.817 | Standard Deviation 1.4662 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Vadadustat 150 mg | 10.460 | Standard Deviation 0.7501 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Vadadustat 300 mg | 11.285 | Standard Deviation 1.7841 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Vadadustat 600 mg | 11.100 | Standard Deviation 1.1402 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Placebo to Vadadustat 150 mg | 8.600 | Standard Deviation 0.9899 | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Placebo to Vadadustat 300 mg | 13.200 | Standard Deviation NA | g/dL | |
| Mean Hb Levels at the End of the Dose Adjustment and Maintenance Period | Placebo to Vadadustat 600 mg | 12.100 | Standard Deviation 1.5556 | g/dL | |
| Number of Participants Who Achieved the Target Hb Level of 10.0 to 12.0 g/dL at the End of the Dose Adjustment and Maintenance Period | Vadadustat 150 mg | 7 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03054350/results